Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma: A Multicenter, Prospective, Non-interventional Study in Germany

NCT07240662 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT07240662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07240662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma: A Multicenter, Prospective, Non-interventional Study in Germany
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Recruiting
Start date
December 8, 2025
Completion date
January 31, 2032
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma